Skip to main content

Table 2 Levels of eosinophils (cells/mm2) and abundance (score) for smooth muscle proteins, periostin, and keratins at baseline (T0) and after 36 months of anti-IgE treatment (T36)

From: Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months

 

OR1

OR2

OR3

OR4

NOR1

NOR2

NOR3

NOR4

Eosinophils

 T0

19

31

58

115

0

10

10

9

 T36

3

9

4

5

11

3

20

27

Smooth muscle proteins

 T0

288

80

198

494

0

0

20

0

 T36

10

20

0

0

168

0

30

98

Periostin

 T0

30

160

130

150

0

30

120

0

 T36

0

0

0

0

20

0

106

20

Keratins

 T0

1990

1902

1630

2047

1404

1910

1892

1676

 T36

574

276

100

266

2106

40

1330

1400

Galectin-3

 T0

10

10

30

20

0

0

0

0

 T36

0

0

0

0

0

0

0

0

  1. Increased values (or substantially unchanged) at T36 compared to T0 are reported in italic. For more details about available proteins see Additional file 2